JP Morgan Chase
BCDA icon

JP Morgan Chase’s BioCardia BCDA Stock Holding History

JP Morgan Chase’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-234
Closed -$456 – 7390
2025
Q2 		$456 Buy
+234
New +$520 ﹤0.01% 6706
2025
Q1 		– Sell
-899
Closed -$1.96K – 7337
2024
Q4 		$1.96K Buy
+899
New +$2.11K ﹤0.01% 6646

Other funds holding BCDA

CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase's BCDA Position: Q3 2025 in Review

JP Morgan Chase sold out of BioCardia (BCDA) in Q3 2025, closing a stake of 234 shares — an estimated $456 sold.

JP Morgan Chase first reported a position in BCDA in Q4 2024 and held it in 2 quarters. The position peaked at $1.96K in Q4 2024. 18 funds tracked by Wall St. Rank hold BCDA as of Q3 2025.

  • JP Morgan Chase reported no remaining BioCardia position as of Q3 2025 after selling out during the quarter.
  • JP Morgan Chase sold 234 BioCardia shares in Q3 2025, an estimated $456.
  • JP Morgan Chase first reported a position in BioCardia in Q4 2024 and held it in 2 quarters.
  • JP Morgan Chase's BioCardia position peaked at $1.96K in Q4 2024.
  • 18 funds tracked by Wall St. Rank held BioCardia as of Q3 2025.

Based on JP Morgan Chase's 13F filing for Q3 2025, filed 7 Nov 2025.